Literature DB >> 2249216

Recurrent pericarditis.

N O Fowler1.   

Abstract

The most common background for recurrent pericarditis is that of acute nonspecific pericarditis. Relapsing pericarditis also may follow cardiac trauma, cardiac operations, myocardial infarction, and intrapericardial bleeding. The exact recurrence rate after initial attacks of idiopathic pericarditis is unknown but appears to be in the range of 15% to 32%. The mechanism of recurrent pericarditis is uncertain. An autoimmune response has been proposed, but this concept is unproved. Yoneda and coworkers, in a case of pericarditis due to coxsackie B virus, found no rise in antibody titer to this virus during recurrences. The prognosis, except for disabling pain and malaise, is good, and constrictive pericarditis, chronic myocardial disease, and cardiac tamponade are unusual complications. Although constrictive pericarditis may follow an initial attack of idiopathic pericarditis, it was reported in neither two other series of patients with relapsing pericarditis nor in this series. Cardiac tamponade has been reported as an occasional complication of relapses but did not occur in our patients. None of our patients died. Most patients with recurrent pericarditis respond to adrenal steroid therapy, but many times there is difficulty in weaning the patient from the drug. Because it is suspected that adrenal steroids may prolong attacks and promote tendency to further recurrences, initial therapy should be offered with aspirin or NSAIDs, and adrenal steroid therapy should be used only when there is no response to these agents. Recurrences may take place over a period lasting as long as 15 years, and patients with as many as 19 recurrences have been described.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2249216

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  8 in total

1.  Surgical treatment for incessant pericarditis.

Authors:  S S Hota; C M Chow; D Bonneau; R J Chisholm
Journal:  Can J Cardiol       Date:  2009-03       Impact factor: 5.223

2.  Efficacy of intravenous immunoglobulin in chronic idiopathic pericarditis: report of four cases.

Authors:  D Peterlana; A Puccetti; S Simeoni; E Tinazzi; R Corrocher; C Lunardi
Journal:  Clin Rheumatol       Date:  2004-07-14       Impact factor: 2.980

3.  Pericardiectomy vs medical management in patients with relapsing pericarditis.

Authors:  Masud H Khandaker; Hartzell V Schaff; Kevin L Greason; Nandan S Anavekar; Raul E Espinosa; Sharonne N Hayes; Rick A Nishimura; Jae K Oh
Journal:  Mayo Clin Proc       Date:  2012-11       Impact factor: 7.616

4.  Idiopathic pericarditis and pericardial effusion in children: contemporary epidemiology and management.

Authors:  Divya Shakti; Rebecca Hehn; Kimberly Gauvreau; Robert P Sundel; Jane W Newburger
Journal:  J Am Heart Assoc       Date:  2014-11-07       Impact factor: 5.501

5.  CEACAM1 and MICA as novel serum biomarkers in patients with acute and recurrent pericarditis.

Authors:  Gal Markel; Massimo Imazio; Nira Koren-Morag; Gilli Galore-Haskel; Jacob Schachter; Michal Besser; Davide Cumetti; Silvia Maestroni; Arie Altman; Yehuda Shoenfeld; Antonio Brucato; Yehuda Adler
Journal:  Oncotarget       Date:  2016-04-05

Review 6.  Recurrent pericarditis: an update on diagnosis and management.

Authors:  Alessandro Andreis; Massimo Imazio; Matteo Casula; Stefano Avondo; Antonio Brucato
Journal:  Intern Emerg Med       Date:  2021-02-28       Impact factor: 3.397

Review 7.  The Use of IL-1 Receptor Antagonist (Anakinra) in Idiopathic Recurrent Pericarditis: A Narrative Review.

Authors:  Shankar Baskar; Allan L Klein; Andrew Zeft
Journal:  Cardiol Res Pract       Date:  2016-01-31       Impact factor: 1.866

8.  Recurrent pericarditis as an extra-intestinal manifestation of ulcerative colitis in a 14-year-old girl.

Authors:  Ann J M Van Gils; Sandra van Gijlswijk; Jan A J M Taminiau; Fabienne Marchau; Els Van De Vijver
Journal:  Clin Case Rep       Date:  2018-06-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.